Depression and heart failure: An association with negative outcomes;Insuficiência cardíaca e depressão: Uma associação com desfechos negativos

Insuficiencia Cardiaca

Volumn 6, Issue 4, 2011, Pages 170-178

  Pena, Felipe Montes ^a   Amorim, Andressa ^b   Fassbender, Cecília ^b   de Freitas Jaber de Oliveira, Raphael ^b   de Faria, Carlos Augusto Cardozo ^a,c  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FACULDADE DE MEDICINA DE CAMPOS   (Brazil)

^c HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

Author keywords

Depression; Heart failure; Mortality

Indexed keywords

EID: 82855177082     PISSN: 18501044     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Sullivan MD, Levy WC, Crane BA, Russo JE, Spertus JA. Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure. Am J Cardiol 2004;94:1577-80.
2. Junger J, Schellberg D, Muller-Tasch T, Raupp G, Zugck C, Haunstetter A, et al. Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail 2005;7:261-7.
3. Pena FM, Carreira MAMQ, Faria CAC, Modenesi RF, Barcelos AF, Piraciaba MCT, et al. Sintomas depressivos e hospitalizacoes por insuficiencia cardiaca: prevalencia, preditores e mortalidade. Insuf Card 2010;5(4):178-184.
4. Sherwood A, Blumenthal JA, Trivedi R, Johnson KS, O'Connor CM, Adams KF. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 2007;167:367-373.
5. Yancy CW. Comprehensive treatment of heart failure: state-ofthe- art medical therapy. Rev Cardiovasc Med 2005; 6(Suppl 2):S43-S57.
6. Havranek EP, Spertus JA, Masoudi FA, Jones PG, Rumsfeld JS. Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol 2004;44;2333-2338.
7. Carney RM, Freedland KE, Stein PK, Skala JA, Hoffman P, Jaffe AL. Chance in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 2000, 62:639-647.
8. Gottlieb SS, Khatta M, Friedmann E, Einbinder L, Katzen S, Baker B, et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 2004;43:1542-1549.
9. Konstam V, Moser DK, De Jong MJ. Depression and anxiety in heart failure. J Card Fail 2005;11:455-463.
10. Joynt KE, Whellan DJ, O'Connor CM. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail 2004;10:258-271.
11. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-18.
12. Laprerie AL, Hossler V, Stora O et al. Education and multidisciplinary management in chronic heart failure. Presse Med 2007; Apr 10 [Epub].
13. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994;154(4):433-437.
14. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med 1997;157:1921-29.
15. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002;17(7):504-11.
16. Glazer KM, Emery CF, Frid DJ, Banyasz RE. Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation. J Cardiopulm Rehabil 2002;22(1):40-6.
17. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: metaanalysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160(14):2101-7.
18. Schweitzer RD, Head K, Dwyer JW. Psychological factors and treatment adherence behavior in patients with chronic heart failure. J Cardiovasc Nurs 2007;22(1):76-83.
19. Krumholz HM, Radford MJ, Wang Y, Jersey Chen, Heiat A, Marcianiak TA. National Use and Effectiveness of beta-Blockers for the Treatment of Elderly Patients After Acute Myocardial Infarction National Cooperative Cardiovascular Project. JAMA. 1998;280(7):623-629.
20. Murberg TA, Furze G. Depressive symptoms and mortality in patients with congestive heart failure: a six-year follow-up study. Med Sci Monit 2004 10(12):CR643-CR648.
21. Struthers AD, Anderson G, Donnanb PT, MacDonald T. Social deprivation increases cardiac hospitalizations in chronic heart failure independent of disease severity and diuretic non-adherence. Heart 2000;83:12-16.
22. Barefoot JC, Brummett BH, Clapp-Channing NE, Siegler IC, Vitaliano PP, Williams RB, et al. Moderators of the effect of social support on depressive symptoms in cardiac patients. Am J Cardiol 2000;86(4):438-42.
23. Barefoot JC, Burg MM, Carney RM, et al. Aspects of social support associated with depression at hospitalization and followup assessment among cardiac patients. J Cardiopulm Rehabil 2003;23(6):404-12.
24. Grippo AJ, Johnson AK. Biological mechanisms in the relationship between depression and heart disease. Neurosci Biobehav Rev 2002;26:941-962.
25. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J 2000;140(4 Suppl):77-83.
26. Yeragani VK, Pesce V, Jayaraman A, Roose S. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures. Biol Psychiatry 2002;52(5):418-29.
27. Blum A, Miller H. Pathophysiological role of cytokines in congestive heart failure. Annu Ver Med 2001;52:15-27.
28. Pasic J, Levy EC, Sullivan MD. Cytokines in depression and heart failure. Psychosom Med 2003;65(2):181-93.
29. Nemeroff CB, Ressler KJ. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety 2000;12(1):2-19.
30. Freedland KE, Rich MW, Skala JA, Carney RM, Davila-Roman VG, Jaffe AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psy Med 2003;65:119-128.
31. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 2003;42:1811-1817.
32. Vaccarino V, Kasl SV, Abramson J, Krumholz HM. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001;38:199-205.
33. Covinsky KE, Fortinsky RH, Palmer RM, Kresevic DM, Landefeld CS. Relation between symptoms of depression and health status outcomes in acutely ill hospitalized older persons. Ann Intern Med 1997;126:417-25.
34. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 1986;6:165-73.
35. Lyness JM, Kelly Noel T, Cox C, King DA, Conwell Y, Caine ED. Screening for depression in elderly primary care patients: a comparison of the Center for Epidemiologic Studies' Depression Scale and the Geriatric Depression Scale. Arch Intern Med 1997;157:449-54.
36. Whooley MA, Browner WS. Association between depressive symptoms and mortality in older women. Arch Intern Med 1998;158:2129-35.
37. Gerety MB, Williams JJ, Mulrow CD, et al. Performance of case-finding tools for depression in the nursing home: influence of clinical and functional characteristics and selection of optimal threshold scores. J Am Geriatr Soc 1994;42:1103-9.
38. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol 1999;84(3):348-50.
39. Pena FM, Soares JS, Paiva BTC, et al. Sociodemographic factors and depressive symptoms in hospitalized patients with heart failure. Exp Clin Cardiol 2010;15(2):e29-e32.
40. Sherwood A, Blumenthal JA, Trivedi R, Johnson KS, O'Connor CM, Adams Jr KF, et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 2007;167:367-373.
41. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004;66:305-315.
42. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001;161:1849-1856.
43. Adams KF, Zannad F. Clinical definition and etiology of advanced heart failure. Am Heart J 1998;135:S204-S215.
44. Bennett SJ, Pressler ML, Hays L, Firestine L, Huster GA. Psychosocial variables and hospitalization in persons with chronic heart failure. Prog Cardiovasc Nurs 1997;12:4-11.
45. Cline MJ, Willenheimer RB, Erdhardt LR, Wiklund I, Israelsson BYA. Health-related quality of life in elderly patients with heart failure. Scand Cardiovasc J 1999;33:278-285.
46. Trzcieniecka-Green A, Steptoe A. Stress management in cardiac patients: a preliminary study of the predictors of improvement in quality of life. J Psychosom Res 1994;38:267-80.
47. Gruen W. Effects of brief psychotherapy during the hospitalization period on the recovery process in heart attacks. J Consult Clin Psychol 1975;43:223-32.
48. Jones DA, West RR. Psychological rehabilitation after myocardial infarction: multicentre randomised controlled trial. BMJ 1996;313:1517-21.
49. Frasure-Smith N, Prince R. The ischemic heart disease life stress monitoring program: impact on mortality. Psychosom Med 1985;47:431-45.
50. Blumenthal JA, Jiang W, Babyak MA, Krantz DS, Frid DJ, Coleman RE, et al. Stress management and exercise training in cardiac patients with myocardial ischemia. Effects on prognosis and evaluation of mechanisms. Arch Intern Med 1997;157:2213-23.
51. Blumenthal JA, Babyak M, Wei J, O'Connor C, Waugh R, Eisenstein E, et al. Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men. Am J Cardiol 2002;89:164-8.
52. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 1996;156:745-52.
53. Lett HS, Blumenthal AJ, Babyak MA, Sherwood A, Strauman T, Robins C, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psy Med 2004;66:305-315.
54. Department of Health and Human Services; Public Health Service; Agency for Health Care Policy and Research. Depression in primary care. Volume 1. Detection and Diagnosis. AHCPR Publication No.93-0550. Rockville, Md: US Department of Health and Human Services; 1993.
55. S Department of Health and Human Services; Public Health Service; Agency for Health Care Policy and Research. Depression in Primary Care. Volume 2. Treatment of Major Depression. AHCPR Publication No. 93-0550. Rockville, Md: US Depart ment of Health and Human Services; 1993.
56. Louis WJ, Doyle AE, Anavekar SN. Plasma noradrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression. Clin Sci Molec Med 1975;2(Suppl):239s-242s.
57. Curtis BM, O'Keefe JH, Jr. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc 2002;77:45-54.
58. Rosenwinkel ET, Bloomfield DM, Arwady MA, Goldsmith RL. Exercise and autonomic function in health and cardiovascular disease. Cardiol Clinics 2001;19:369-87.
59. Brook RD, Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 2000;13:t-122S.
60. Dakak N, Quyyumi AA, Eisenhofer G, Goldstein DS, Cannon RO. Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. Am J Cardiol 1995;76:125-30.
61. Hossack KF, Brown BG, Stewart DK, Dodge HT. Diltiazeminduced blockade of sympathetically mediated constriction of normal and diseased coronary arteries: lack of epicardial coronary dilatory effect in humans. Circulation 1984;70:465-71.
62. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995;76:562-4.
63. Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001;104:2024-8.
64. Krittayaphong R, Cascio WE, Light KC, Sheffield D, Golden RN, Finkel JB, et al. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med 1997;59:231-5.
65. Stein PK, Carney RM, Freedland KE, Skala JA, Jaffe AS, Kleiger RE, et al. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res 2000;48:493-500.
66. Watkins LL, Grossman P. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J 1999;137:453-7.
67. Milani RV, Lavie CJ, Cassidy MM. Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events. Am Heart J 1996;132:726-32.
68. Fava M, Rosenbaum JF. Pharmacotherapy and somatic therapies. In: Beckham EE, Leber WR, editors. Handbook of Depression. New York: The Guilford Press; 1995.
69. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 1996;156:745-52.
70. Craighead WE, Hart AB, Craighead LW, Ilardi SS. Psychosocial treatments for major depressive disorder. In: Nathan P, Gorman JM, editors. A guide to treatments that work. New York: Oxford University Press; 2002.
71. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, et al. SADHEART Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-9.
72. Writing committee for the ENRICHD investigators. Effects of treating depression and low social support on clinical events after myocardial infarction: The enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. JAMA 2003;289:3106-16.
73. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT, Jr, Pollock BG, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287-91.
74. Shapiro PA, Lesperance F, Frasure-Smith N, O'Connor CM, Baker B, Jiang JW, et al. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial. Am Heart J 1999;137:1100-6.
75. Nair GV, Gurbel PA, O'Connor CM, Gattis WA, Murugesan SR, Serebruany VL. Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors. Am J Cardiol 1999;84:321-3.
76. Brosse AL, Sheets ES, Lett HS, Blumenthal JA. Exercise and the treatment of clinical depression in adults: recent findings and future directions. Sports Med 2002;32:741-760.
77. Milani RV, Lavie CJ. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med 2007;120:799-806.
78. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC; National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-2372.